 Elizabeth Morris
Concepts (192)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| SAM Domain and HD Domain-Containing Protein 1 | 6 | 2024 | 12 | 2.330 |
Why?
| | Virus Replication | 5 | 2025 | 529 | 0.820 |
Why?
| | Models, Molecular | 11 | 2025 | 1619 | 0.790 |
Why?
| | RNA-Binding Proteins | 4 | 2025 | 464 | 0.710 |
Why?
| | Transposases | 3 | 2016 | 19 | 0.690 |
Why?
| | Deoxyribonucleotides | 1 | 2021 | 20 | 0.690 |
Why?
| | Nucleoside-Triphosphatase | 1 | 2020 | 14 | 0.650 |
Why?
| | Crystallography, X-Ray | 8 | 2025 | 493 | 0.640 |
Why?
| | Catalytic Domain | 6 | 2025 | 234 | 0.610 |
Why?
| | Weight Reduction Programs | 1 | 2021 | 137 | 0.600 |
Why?
| | Water | 1 | 2020 | 469 | 0.500 |
Why?
| | Ethylene Glycols | 1 | 2015 | 17 | 0.470 |
Why?
| | Stilbenes | 1 | 2015 | 33 | 0.460 |
Why?
| | Benzothiazoles | 1 | 2015 | 40 | 0.460 |
Why?
| | DNA Transposable Elements | 1 | 2016 | 122 | 0.450 |
Why?
| | Recombination, Genetic | 1 | 2016 | 205 | 0.440 |
Why?
| | Aniline Compounds | 1 | 2015 | 119 | 0.440 |
Why?
| | Endoribonucleases | 2 | 2025 | 80 | 0.440 |
Why?
| | Radiopharmaceuticals | 1 | 2015 | 207 | 0.430 |
Why?
| | Pseudomonas aeruginosa | 2 | 2014 | 356 | 0.410 |
Why?
| | Positron-Emission Tomography | 1 | 2015 | 343 | 0.410 |
Why?
| | DNA-Binding Proteins | 3 | 2016 | 1500 | 0.400 |
Why?
| | DNA | 3 | 2018 | 1464 | 0.400 |
Why?
| | Antiviral Agents | 1 | 2019 | 768 | 0.390 |
Why?
| | Protein Folding | 2 | 2012 | 279 | 0.390 |
Why?
| | Allosteric Regulation | 3 | 2024 | 98 | 0.370 |
Why?
| | Monomeric GTP-Binding Proteins | 2 | 2023 | 15 | 0.370 |
Why?
| | Hypertension | 1 | 2021 | 1264 | 0.360 |
Why?
| | Catalysis | 3 | 2024 | 322 | 0.340 |
Why?
| | Hydrolysis | 2 | 2021 | 199 | 0.320 |
Why?
| | HIV-1 | 5 | 2024 | 896 | 0.300 |
Why?
| | Alzheimer Disease | 1 | 2015 | 622 | 0.290 |
Why?
| | Bacterial Proteins | 2 | 2013 | 962 | 0.290 |
Why?
| | Protein Conformation | 3 | 2020 | 946 | 0.280 |
Why?
| | Proteins | 1 | 2012 | 1022 | 0.230 |
Why?
| | Manganese | 1 | 2025 | 55 | 0.230 |
Why?
| | Protein Binding | 5 | 2019 | 2276 | 0.200 |
Why?
| | Cryoelectron Microscopy | 1 | 2024 | 222 | 0.190 |
Why?
| | Dissent and Disputes | 1 | 2022 | 18 | 0.190 |
Why?
| | Bone Regeneration | 2 | 2019 | 28 | 0.180 |
Why?
| | Deoxyguanine Nucleotides | 1 | 2021 | 12 | 0.170 |
Why?
| | Collagen Type X | 1 | 2020 | 14 | 0.160 |
Why?
| | Polyphosphates | 1 | 2020 | 45 | 0.160 |
Why?
| | Osteogenesis | 2 | 2019 | 208 | 0.160 |
Why?
| | Autoimmune Diseases of the Nervous System | 1 | 2020 | 31 | 0.160 |
Why?
| | Mutation | 3 | 2020 | 4099 | 0.160 |
Why?
| | Fracture Healing | 1 | 2020 | 91 | 0.150 |
Why?
| | Nervous System Malformations | 1 | 2020 | 47 | 0.150 |
Why?
| | Tibial Fractures | 1 | 2020 | 72 | 0.150 |
Why?
| | Collateral Ligament, Ulnar | 1 | 2019 | 5 | 0.150 |
Why?
| | Interferons | 1 | 2020 | 188 | 0.140 |
Why?
| | Myoblasts, Skeletal | 1 | 2018 | 12 | 0.140 |
Why?
| | Elbow | 1 | 2019 | 57 | 0.140 |
Why?
| | Patient Safety | 1 | 2022 | 349 | 0.140 |
Why?
| | Nucleotides | 1 | 2019 | 128 | 0.140 |
Why?
| | Prosencephalon | 1 | 2018 | 53 | 0.140 |
Why?
| | Elbow Joint | 1 | 2019 | 74 | 0.140 |
Why?
| | Ligaments, Articular | 1 | 2018 | 54 | 0.140 |
Why?
| | Humans | 19 | 2025 | 144957 | 0.140 |
Why?
| | Menisci, Tibial | 1 | 2018 | 78 | 0.140 |
Why?
| | Chondrogenesis | 1 | 2019 | 88 | 0.140 |
Why?
| | Knee Joint | 2 | 2018 | 426 | 0.130 |
Why?
| | Phosphoric Diester Hydrolases | 1 | 2018 | 53 | 0.130 |
Why?
| | Stem Cell Transplantation | 1 | 2019 | 191 | 0.130 |
Why?
| | Brachial Artery | 1 | 2019 | 206 | 0.130 |
Why?
| | Kinetics | 1 | 2021 | 1629 | 0.130 |
Why?
| | Biological Therapy | 1 | 2017 | 28 | 0.130 |
Why?
| | Selection, Genetic | 1 | 2019 | 256 | 0.130 |
Why?
| | Protein Domains | 3 | 2025 | 313 | 0.130 |
Why?
| | DNA, Viral | 1 | 2019 | 358 | 0.130 |
Why?
| | Platelet-Rich Plasma | 1 | 2017 | 41 | 0.130 |
Why?
| | Inverted Repeat Sequences | 2 | 2014 | 18 | 0.130 |
Why?
| | Nucleic Acid Conformation | 2 | 2018 | 726 | 0.120 |
Why?
| | Hepatitis B | 1 | 2017 | 66 | 0.120 |
Why?
| | Host-Pathogen Interactions | 1 | 2019 | 371 | 0.120 |
Why?
| | Binding Sites | 3 | 2014 | 1331 | 0.120 |
Why?
| | Bone Marrow Cells | 1 | 2017 | 320 | 0.120 |
Why?
| | Tissue Donors | 1 | 2018 | 424 | 0.110 |
Why?
| | DNA Repair | 1 | 2018 | 256 | 0.110 |
Why?
| | Homeostasis | 1 | 2019 | 640 | 0.110 |
Why?
| | Evolution, Molecular | 1 | 2019 | 515 | 0.110 |
Why?
| | Weight Loss | 1 | 2021 | 837 | 0.110 |
Why?
| | Protein Stability | 2 | 2014 | 178 | 0.110 |
Why?
| | DNA Damage | 1 | 2018 | 430 | 0.110 |
Why?
| | Liver Cirrhosis | 1 | 2017 | 288 | 0.110 |
Why?
| | Homeodomain Proteins | 1 | 2018 | 524 | 0.110 |
Why?
| | Stem Cells | 1 | 2019 | 627 | 0.110 |
Why?
| | Hepatitis C | 1 | 2017 | 254 | 0.100 |
Why?
| | Blood Pressure | 1 | 2021 | 1769 | 0.100 |
Why?
| | Base Sequence | 2 | 2018 | 2191 | 0.100 |
Why?
| | Pyrrolidinones | 1 | 2014 | 29 | 0.100 |
Why?
| | Osteoarthritis, Knee | 1 | 2017 | 279 | 0.100 |
Why?
| | Immunity, Innate | 1 | 2019 | 846 | 0.100 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2018 | 906 | 0.100 |
Why?
| | Hydrogen Bonding | 1 | 2013 | 169 | 0.100 |
Why?
| | Hydrophobic and Hydrophilic Interactions | 1 | 2013 | 192 | 0.090 |
Why?
| | Thermodynamics | 2 | 2012 | 426 | 0.090 |
Why?
| | Protein Structure, Secondary | 1 | 2013 | 369 | 0.090 |
Why?
| | RNA, Bacterial | 1 | 2013 | 189 | 0.090 |
Why?
| | Body Mass Index | 1 | 2021 | 2438 | 0.090 |
Why?
| | Protein Denaturation | 1 | 2012 | 75 | 0.090 |
Why?
| | Muscle, Skeletal | 2 | 2019 | 1796 | 0.090 |
Why?
| | Cell Proliferation | 1 | 2019 | 2499 | 0.090 |
Why?
| | Sequence Analysis, RNA | 1 | 2014 | 442 | 0.090 |
Why?
| | Anti-Retroviral Agents | 1 | 2014 | 250 | 0.090 |
Why?
| | RNA, Viral | 2 | 2025 | 688 | 0.090 |
Why?
| | Protein Structure, Tertiary | 1 | 2013 | 862 | 0.080 |
Why?
| | Repressor Proteins | 1 | 2014 | 437 | 0.080 |
Why?
| | Amino Acid Sequence | 1 | 2013 | 2157 | 0.070 |
Why?
| | Molecular Sequence Data | 1 | 2013 | 2931 | 0.070 |
Why?
| | Mice, Inbred ICR | 2 | 2019 | 113 | 0.070 |
Why?
| | Middle Aged | 3 | 2021 | 35928 | 0.070 |
Why?
| | Case-Control Studies | 1 | 2015 | 3608 | 0.070 |
Why?
| | Cadaver | 2 | 2019 | 304 | 0.070 |
Why?
| | Aging | 1 | 2018 | 1966 | 0.070 |
Why?
| | Reproducibility of Results | 1 | 2015 | 3415 | 0.070 |
Why?
| | Obesity | 1 | 2021 | 3082 | 0.060 |
Why?
| | Phosphorylation | 2 | 2023 | 1733 | 0.060 |
Why?
| | Algorithms | 1 | 2014 | 1839 | 0.060 |
Why?
| | RNA, Messenger | 1 | 2014 | 2832 | 0.060 |
Why?
| | Animals | 6 | 2020 | 38109 | 0.060 |
Why?
| | Aged | 4 | 2019 | 25947 | 0.050 |
Why?
| | Protein Structure, Quaternary | 1 | 2024 | 116 | 0.050 |
Why?
| | Biocatalysis | 1 | 2024 | 69 | 0.050 |
Why?
| | Sex Characteristics | 2 | 2020 | 791 | 0.050 |
Why?
| | U937 Cells | 1 | 2023 | 27 | 0.050 |
Why?
| | RNA-Directed DNA Polymerase | 1 | 2023 | 35 | 0.050 |
Why?
| | Radiologists | 1 | 2022 | 61 | 0.040 |
Why?
| | Male | 6 | 2020 | 72406 | 0.040 |
Why?
| | Mice | 4 | 2020 | 18365 | 0.040 |
Why?
| | Cell Differentiation | 2 | 2019 | 2050 | 0.040 |
Why?
| | vpr Gene Products, Human Immunodeficiency Virus | 1 | 2019 | 2 | 0.040 |
Why?
| | Biological Coevolution | 1 | 2019 | 2 | 0.040 |
Why?
| | Viral Regulatory and Accessory Proteins | 1 | 2019 | 27 | 0.040 |
Why?
| | Lentivirus | 1 | 2018 | 60 | 0.040 |
Why?
| | Tyrosine | 1 | 2019 | 222 | 0.040 |
Why?
| | Bone Morphogenetic Protein 2 | 1 | 2018 | 77 | 0.030 |
Why?
| | Transduction, Genetic | 1 | 2018 | 133 | 0.030 |
Why?
| | Cartilage Diseases | 1 | 2018 | 45 | 0.030 |
Why?
| | Alcohol Oxidoreductases | 1 | 2018 | 62 | 0.030 |
Why?
| | Conserved Sequence | 1 | 2018 | 245 | 0.030 |
Why?
| | Mice, SCID | 1 | 2018 | 369 | 0.030 |
Why?
| | Chromosomal Proteins, Non-Histone | 1 | 2018 | 132 | 0.030 |
Why?
| | Knee Injuries | 1 | 2018 | 122 | 0.030 |
Why?
| | Interneurons | 1 | 2018 | 128 | 0.030 |
Why?
| | State Medicine | 1 | 2017 | 27 | 0.030 |
Why?
| | Tibia | 1 | 2018 | 176 | 0.030 |
Why?
| | Female | 4 | 2020 | 78376 | 0.030 |
Why?
| | Enhancer Elements, Genetic | 1 | 2018 | 192 | 0.030 |
Why?
| | Technology Assessment, Biomedical | 1 | 2017 | 44 | 0.030 |
Why?
| | Injections | 1 | 2017 | 197 | 0.030 |
Why?
| | Models, Genetic | 1 | 2019 | 536 | 0.030 |
Why?
| | Neurogenesis | 1 | 2018 | 157 | 0.030 |
Why?
| | RNA, Long Noncoding | 1 | 2018 | 178 | 0.030 |
Why?
| | United Kingdom | 1 | 2017 | 338 | 0.030 |
Why?
| | Bone and Bones | 1 | 2018 | 315 | 0.030 |
Why?
| | Cartilage, Articular | 1 | 2018 | 343 | 0.030 |
Why?
| | Cell Cycle Proteins | 1 | 2018 | 629 | 0.030 |
Why?
| | Simian foamy virus | 1 | 2014 | 3 | 0.030 |
Why?
| | DNA Cleavage | 1 | 2014 | 8 | 0.030 |
Why?
| | Cations, Divalent | 1 | 2014 | 47 | 0.030 |
Why?
| | Raltegravir Potassium | 1 | 2014 | 18 | 0.030 |
Why?
| | Enzyme Stability | 1 | 2014 | 73 | 0.030 |
Why?
| | Solutions | 1 | 2014 | 167 | 0.020 |
Why?
| | Magnesium | 1 | 2014 | 155 | 0.020 |
Why?
| | HIV Integrase | 1 | 2014 | 74 | 0.020 |
Why?
| | Genome, Bacterial | 1 | 2014 | 156 | 0.020 |
Why?
| | Plasmids | 1 | 2014 | 379 | 0.020 |
Why?
| | Protein Multimerization | 1 | 2014 | 214 | 0.020 |
Why?
| | Sensitivity and Specificity | 1 | 2017 | 1990 | 0.020 |
Why?
| | Escherichia coli Proteins | 1 | 2014 | 206 | 0.020 |
Why?
| | Gene Expression Regulation, Bacterial | 1 | 2014 | 328 | 0.020 |
Why?
| | Software | 1 | 2017 | 692 | 0.020 |
Why?
| | Adult | 3 | 2019 | 40506 | 0.020 |
Why?
| | Age Factors | 1 | 2018 | 3335 | 0.020 |
Why?
| | Temperature | 1 | 2014 | 679 | 0.020 |
Why?
| | Recombinant Proteins | 1 | 2014 | 1371 | 0.020 |
Why?
| | Transcription Factors | 1 | 2018 | 1742 | 0.020 |
Why?
| | Escherichia coli | 1 | 2014 | 855 | 0.020 |
Why?
| | Mice, Inbred C57BL | 1 | 2020 | 5997 | 0.020 |
Why?
| | Biomarkers | 1 | 2020 | 4275 | 0.020 |
Why?
| | Dimerization | 1 | 2008 | 194 | 0.020 |
Why?
| | Haemophilus influenzae | 1 | 2008 | 67 | 0.020 |
Why?
| | Liver | 1 | 2017 | 1888 | 0.020 |
Why?
| | Proline | 1 | 2008 | 83 | 0.020 |
Why?
| | Disease Models, Animal | 1 | 2018 | 4569 | 0.020 |
Why?
| | Point Mutation | 1 | 2008 | 243 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2019 | 8279 | 0.020 |
Why?
| | United States | 1 | 2022 | 15988 | 0.010 |
Why?
| | Young Adult | 1 | 2019 | 14126 | 0.010 |
Why?
| | Treatment Outcome | 1 | 2017 | 11695 | 0.010 |
Why?
| | Child | 1 | 2019 | 22657 | 0.010 |
Why?
|
|
Morris's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|